drugset / Trial / NCT02187588

Study to Assess the Kinetic of the Analgesic Effect and Tolerability of Eschscholtzia Californica Versus Ibuprofen and Placebo in the Treatment of Pain After Surgery of the Third Molar

NCT02187588

Phase 2 Completed 200 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

Study to determine the kinetic of the analgesic effect of 500 mg and 1000 mg of Eschscholtzia Californica per os and placebo in patients undergoing dental surgery over an observation period of 6 hours. In a secondary analysis, kinetic of analgesic effect comparison between Eschscholtzia californica 500 mg, 1000 mg and Ibuprofen 200 mg

Timeline

Start
1998-02
Primary completion
1999-05
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Eschscholtzia Californica Unknown 500 mg Oral
Subject Eschscholtzia Californica Unknown 1000 mg Oral
Comparator Ibuprofen Small molecule 200 mg

Indications

No indication recorded.